The Exchange: How UK’s vaccine taskforce did it

1 minute read

A vial, sryinge and small toy figures are seen in front of a displayed UK flag in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

LONDON, Aug 3 (Reuters Breakingviews) - Clive Dix was part of a crack team of business execs and scientists that secured Covid-19 jabs for Great Britain. They applied a venture capital approach that can be used to tackle other public sector challenges. The former chairman discusses lessons learned and looming threats.

Listen to the podcast

Follow @aimeedonnellan on Twitter

Editing by Craig Hettich, Katrina Hamlin and Amanda Gomez

Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.

More from Reuters